Form 4 for CRVL CORVEL CORP
Accepted 2021-11-29 00:00:00 ET · period of report 2021-11-24 · accession 0001754499-21-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-29 | 2021-11-24 | CRVL | O'Brien Brandon | CFO | M - OptEx | $75.75 | +441 | 2,789 | +19% | +$33.4K |
| DM | 2021-11-29 | 2021-11-24 | CRVL | O'Brien Brandon | CFO | S - Sale+OE | $200.00 | -441 | 2,656 | -14% | -$88.2K |
| DM | 2021-11-29 | 2021-11-24 | CRVL | O'Brien Brandon | CFO | M - OptEx | $0.00 | -441 | 175 | -72% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | M | A | 83 | $70.24 | 2,739 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-24 | S | D | 83 | $200.00 | 2,656 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-24 | M | A | 225 | $87.49 | 2,881 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-24 | S | D | 133 | $200.00 | 2,656 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-24 | M | A | 133 | $59.32 | 2,789 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-24 | S | D | 225 | $200.00 | 2,656 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-24 | M | D | 83 | $0.00 | 375 | D | $70.24 · — to 2024-04-25 | 83 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-24 | M | D | 133 | $0.00 | 3,200 | D | $59.32 · — to 2023-11-01 | 133 Common Stock | (F1) Option will vest based on achievement of certain performance criteria relating to earnings growth. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-24 | M | D | 225 | $0.00 | 175 | D | $87.49 · — to 2024-08-08 | 225 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |